- Home
- VINC vs BGLC Comparison
VINC vs BGLC Comparison
Compare VINC & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VINC
- BGLC
- Stock Information
- Founded
- VINC 2019
- BGLC 2017
- Country
- VINC United States
- BGLC Malaysia
- Employees
- VINC N/A
- BGLC N/A
- Industry
- VINC Biotechnology: Pharmaceutical Preparations
- BGLC Medical Specialities
- Sector
- VINC Health Care
- BGLC Health Care
- Exchange
- VINC Nasdaq
- BGLC Nasdaq
- Market Cap
- VINC 6.2M
- BGLC 5.8M
- IPO Year
- VINC N/A
- BGLC N/A
- Fundamental
- Price
- VINC $1.24
- BGLC $0.35
- Analyst Decision
- VINC Buy
- BGLC
- Analyst Count
- VINC 2
- BGLC 0
- Target Price
- VINC $40.00
- BGLC N/A
- AVG Volume (30 Days)
- VINC 1.1M
- BGLC 177.5K
- Earning Date
- VINC 03-28-2025
- BGLC 03-04-2025
- Dividend Yield
- VINC N/A
- BGLC N/A
- EPS Growth
- VINC N/A
- BGLC N/A
- EPS
- VINC N/A
- BGLC N/A
- Revenue
- VINC N/A
- BGLC $9,259,858.00
- Revenue This Year
- VINC N/A
- BGLC N/A
- Revenue Next Year
- VINC N/A
- BGLC N/A
- P/E Ratio
- VINC N/A
- BGLC N/A
- Revenue Growth
- VINC N/A
- BGLC N/A
- 52 Week Low
- VINC $1.18
- BGLC $0.21
- 52 Week High
- VINC $187.44
- BGLC $1.20
- Technical
- Relative Strength Index (RSI)
- VINC 28.95
- BGLC 46.44
- Support Level
- VINC $1.18
- BGLC $0.33
- Resistance Level
- VINC $1.38
- BGLC $0.40
- Average True Range (ATR)
- VINC 0.11
- BGLC 0.02
- MACD
- VINC 0.09
- BGLC -0.01
- Stochastic Oscillator
- VINC 12.50
- BGLC 23.07
About VINC Vincerx Pharma Inc.
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.